-
Mashup Score: 0Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission - 7 hour(s) ago
Molecular MRD after induction chemotherapy identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission.Patients achieving M
Source: ashpublications.orgCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 28
In a pair of Special Reports, Gökbuget and colleagues present updated European Leukemia Net (ELN) consensus reports on (1) the diagnosis, prognostic factor
Source: ashpublications.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 8Prothrombin forced into an awkward position - 11 hour(s) ago
In this issue of Blood, Kumar et al use a model antibody to show that a subpopulation of antiprothrombin antibodies found in people with antiphospholipid s
Source: ashpublications.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 6Connecting the dots from let-7 to HIC2 to HBG - 13 hour(s) ago
In this issue of Blood, Huang et al1 show that HIC2 messenger RNA (mRNA) is a direct target of let-7 microRNA (miRNA), providing a crucial link between LIN
Source: ashpublications.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Systems medicine dissection of chr1q-amp reveals a novel PBX1-FOXM1 axis for targeted therapy in multiple myeloma - 14 hour(s) ago
Amplification of chromosome 1q (chr1q-amp) is an adverse prognostic feature in multiple myeloma (MM). In this Plenary paper, Trasanidis and colleagues perf
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 10Is estimated exposure an accurate surrogate for measured fludarabine levels in patients with CAR T-cell therapy? - 14 hour(s) ago
TO THE EDITOR:
Source: ashpublications.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Inadequate Sars-Cov-2 Vaccine Effectiveness in Patients with Multiple Myeloma: A Large Nationwide Veterans Affairs Study - 15 hour(s) ago
Abstract. IntroductionCoronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, is particularly serious in patients with multiple myeloma (MM),
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2Racial and Ethnic Differences in Clonal Hematopoiesis, Tumor Markers, and Clinical Outcomes of Patients with Multiple Myeloma - 15 hour(s) ago
Abstract. Background: Multiple myeloma (MM) is twice as common in Blacks compared to Non-Hispanic (NH) Whites and Hispanics. While treatment and mortality
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet-
Racial and Ethnic Differences in Clonal Hematopoiesis, Tumor Markers, & Clinical Outcomes of Patients with Multiple Myeloma [Nov 5, 2021; oral: 12/12/21] @nancykgillis et al. Abstract 402 #ASH21 https://t.co/OvQlaQLOEX #mmsm #cancerdisparities SETD2 (6% Blck v 1% Wht, p = 0.037) https://t.co/9AwP5wjZTU
-
-
Mashup Score: 4FISH and WGS in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma - WGS Will Affect Future Treatment Decisions - 15 hour(s) ago
Abstract. Background:FISH is the gold standard for genetic characterization and risk stratification of multiple myeloma (MM) at diagnosis. Retrospective st
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need - 15 hour(s) ago
Pemmaraju and colleagues of the North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium summarize the latest biological insights, the import
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
Patients achieving MRD negativity in blood after second induction show no survival benefit from CR1 transplant, even if FLT3-ITD comutated. https://t.co/f7SKPiFawb #clinicaltrialsandobservations #myeloidneoplasia #transplantion https://t.co/801miebx9t